| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35263-100ug | |||
| Carrier-Free | NBP2-35263-500ug | |||
| Carrier-Free | NBP2-35263-1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50238-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75913SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-59722-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50188-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26630-50ul | |||
![SDS-Page: Rat LIF Protein [NBP2-35263]](http://images.novusbio.com/fullsize/Rat-LIF-Protein-SDS-Page-NBP2-35263-img0001.jpg "SDS-Page: Rat LIF Protein [NBP2-35263]")
![Immunocytochemistry /Immunofluorescence: KRAS Antibody (D113) - Mutant - BSA Free [NBP3-43583] - Immunofluorescence analysis of paraformaldehyde fixed THP-1 cells on Shi-fix coverslips stained with NBP3-43583 (1:100 dilution) for 1h followed by Alexa Fluor 488 secondary antibody (1:1000 dilution), showing membrane and cytoplasmic staining. The nuclear stain is DAPI (blue). Panels show, from left-right, top-bottom, NBP3-43583, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp3-43583_rabbit-kras-mab-d113-mutant-74202522113037.png "Immunocytochemistry /Immunofluorescence: KRAS Antibody (D113) - Mutant - BSA Free [NBP3-43583] - Immunofluorescence analysis of paraformaldehyde fixed THP-1 cells on Shi-fix coverslips stained with NBP3-43583 (1:100 dilution) for 1h followed by Alexa Fluor 488 secondary antibody (1:1000 dilution), showing membrane and cytoplasmic staining. The nuclear stain is DAPI (blue). Panels show, from left-right, top-bottom, NBP3-43583, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor 488 secondary antibody.")
![SDS-Page: Recombinant Human IGF-II Protein [NBP2-59722] - Recombinant IGF-II Protein [NBP2-59722] - 98 % by SDS-PAGE and HPLC analyses.](http://images.novusbio.com/fullsize/Recombinant-Human-IGF-II-Protein-SDS-Page-NBP2-59722-img0002.jpg "SDS-Page: Recombinant Human IGF-II Protein [NBP2-59722] - Recombinant IGF-II Protein [NBP2-59722] - 98 % by SDS-PAGE and HPLC analyses.")
![SDS-Page: Recombinant Human SPARC Protein [NBP2-61362]](http://images.novusbio.com/fullsize/nbp2-61362_recombinant-human-sparc-protein-512024857297.png "SDS-Page: Recombinant Human SPARC Protein [NBP2-61362]")
![ELISA: Human OX40/TNFRSF4 ELISA Kit (Colorimetric) [NBP2-22043]](http://images.novusbio.com/fullsize/Human-OX40-TNFRSF4-ELISA-Kit-Colorimetric-ELISA-NBP2-22043-img0001.jpg "ELISA: Human OX40/TNFRSF4 ELISA Kit (Colorimetric) [NBP2-22043]")
![Flow Cytometry: GADD153/CHOP Antibody (17A10) [NBP3-26630] - Overlay Peak curve showing Hela cells stained with GADD153/CHOP Antibody (17A10) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26630_rabbit-gadd153-chop-mab-17a10-282202414183624.jpg "Flow Cytometry: GADD153/CHOP Antibody (17A10) [NBP3-26630] - Overlay Peak curve showing Hela cells stained with GADD153/CHOP Antibody (17A10) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")